|
SHROOM4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.591790E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.93859999999746E-05 |
| Normal-vs-Stage2 |
6.041800E-01 |
| Normal-vs-Stage3 |
2.371200E-01 |
| Normal-vs-Stage4 |
1.999940E-03 |
| Stage1-vs-Stage2 |
6.982200E-03 |
| Stage1-vs-Stage3 |
3.2777999999789E-06 |
| Stage1-vs-Stage4 |
1.03940001050518E-09 |
| Stage2-vs-Stage3 |
7.751400E-01 |
| Stage2-vs-Stage4 |
9.949500E-02 |
| Stage3-vs-Stage4 |
8.981600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.116590E-01 |
| Normal-vs-AfricanAmerican |
6.320400E-01 |
| Normal-vs-Asian |
4.508600E-01 |
| Caucasian-vs-AfricanAmerican |
1.890370E-01 |
| Caucasian-vs-Asian |
5.644200E-01 |
| AfricanAmerican-vs-Asian |
2.359800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.466200E-01 |
| Normal-vs-Female |
3.307700E-02 |
| Male-vs-Female |
1.198000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.619000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.755740E-02 |
| Normal-vs-Age(61-80Yrs) |
9.601200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.856400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.968800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.421400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.682400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.435600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.434000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.894800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.123960E-02 |
| Normal-vs-Grade 2 |
7.90880000000049E-05 |
| Normal-vs-Grade 3 |
4.187200E-01 |
| Normal-vs-Grade 4 |
1.435990E-04 |
| Grade 1-vs-Grade 2 |
1.520210E-02 |
| Grade 1-vs-Grade 3 |
8.199900E-03 |
| Grade 1-vs-Grade 4 |
1.415500E-03 |
| Grade 2-vs-Grade 3 |
3.54840000005296E-06 |
| Grade 2-vs-Grade 4 |
1.48139944755599E-10 |
| Grade 3-vs-Grade 4 |
2.200400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.39119999648707E-08 |
| Normal-vs-ccB subtype |
1.580810E-01 |
| ccA subtype-vs-ccB subtype |
4.54310000730374E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.538200E-01 |
| Normal-vs-N1 |
9.412400E-02 |
| N0-vs-N1 |
7.669900E-02 |
|
|
